ASH posts a third-quarter loss of $742 million and misses on sales as portfolio cuts weigh. Full-year guidance range is narrowed.

CVS Health boosts 2025 EPS guidance again as Health Care Benefits and PBM businesses drive growth.

Camtek (CAMT) came out with quarterly earnings of $0.79 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.66 per share a year ago.

ImmunityBio (IBRX) came out with a quarterly loss of $0.1 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.2 per share a year ago.

LGI Homes (LGIH) came out with quarterly earnings of $1.36 per share, beating the Zacks Consensus Estimate of $1.21 per share. This compares to earnings of $2.48 per share a year ago.

Kinsale Capital Group's disciplined underwriting and strategic diversification drive robust performance and a healthy balance sheet, supporting long-term sustainability and dividend growth. Recent price decline has made KNSL shares attractively valued, with P/E, P/B, and DCF models all indicating significant upside potential. Despite bearish technical signals, the stock appears oversold, presenting a favorable entry point for investors seeking value and growth.

First Watch Restaurant Group, Inc. (FWRG) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.14 per share a year ago.

Neuronetics (STIM) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to a loss of $0.33 per share a year ago.

908 Devices Inc. (MASS) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to a loss of $0.32 per share a year ago.

Beijing, Aug. 05, 2025 (GLOBE NEWSWIRE) -- KUKE MUSIC HOLDING LIMITED (“Kuke” or the “Company”) (NYSE: KUKE), a leading classical music service platform in China, today announced that it received notification from the New York Stock Exchange (the “NYSE”) on June 30, 2025, confirming that the Company is now back in compliance with the NYSE's quantitative continued listing standards. This decision came as a result of the Company's achievement of compliance with the NYSE's minimum market capitalization and shareholders' equity requirement of Section 802.01B of the NYSE Listed Company Manual as of the end of the 9-month plan period, which …

Dan Ives, Wedbush Securities global head of tech research, Wall Street continues to underestimate Palantir. The data software company says revenue rose by 48% in the second quarter thanks to the "astonishing impact" of artificial intelligence on its business.

Greenlight Capital Re (GLRE 0.55%), a specialty property and casualty reinsurer, reported second quarter 2025 results on August 4, 2025. The release showed notable improvement in core underwriting, with a sharp turnaround in insurance profitability compared to Q2 2024.

Washington, D.C., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO; CSE: DPRO; FSE: 3U8A), an award-winning, industry-leading developer of drone solutions and systems, proudly participated at the Pentagon's Low-Cost Uncrewed Combat Attack Systems (“LUCAS”) at a recent invite-only event. Selected by MMS Products, Inc. (“MMS”), the developer of the Mjolnir Modular Munition System (“Mjolnir”), Draganfly's UAV platforms were showcased with integrated kinetic payload capabilities, demonstrating the future of low-cost, scalable, autonomous lethality for modern conflict.

Let's take a look at four stocks, CHEF, PRDO, ATGE and NOMD, with impressive net profit margins for a robust portfolio.

Axcelis Technologies (ACLS) came out with quarterly earnings of $1.13 per share, beating the Zacks Consensus Estimate of $0.73 per share. This compares to earnings of $1.55 per share a year ago.

AC Immune (ACIU) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.2. This compares to a loss of $0.25 per share a year ago.

AxoGen (AXGN) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.05 per share a year ago.

Beam Therapeutics Inc. (BEAM) came out with a quarterly loss of $1 per share versus the Zacks Consensus Estimate of a loss of $1.04. This compares to a loss of $1.11 per share a year ago.

Cushman & Wakefield (CWK) came out with quarterly earnings of $0.3 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.2 per share a year ago.

Fidelity National Information Services (FIS) came out with quarterly earnings of $1.36 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $1.36 per share a year ago.